I hope I'm wrong but...The latest court filing by PricewaterhouseCoopers said the purchase by 2092248 Ontario requires reaching an accord by June 20 with ProMetic Bioscience Ltd. of Montreal to continue licensing its cascade technology to strip therapeutic proteins from blood plasma at Hemosol's plant in Mississauga.
What I understand of it is not an obligation to use cascade in the transaction. If Melnyk want to buy the plant without using cascade, we will have nothing. But, if he want, we'll have some fees and gel sale.